Click on the link below to go directly to any of the following sections:
ISOPP Symposia offer oncology pharmacy experts informative, engaging and cutting edge programming in world-class locations.
There are topical plenary sessions, concurrent sessions with three streams (Clinical, Research and Fundamental), poster presentations and, of course, numerous opportunities to network and connect with old friends and new colleagues.
In this new age of anticancer therapy, there is no better place to establish and build relationships with oncology pharmacist colleagues with a wealth of local, regional, national and international experience.
Who attends
ISOPP Symposia attract audiences of more than 500 people from around the world, providing excellent opportunities to establish and cultivate valuable relationships with leaders and pioneers in the field of Oncology Pharmacy.
Attendees include:
- Pharmacists
- Pharmacy Technicians and Assistants
- Cancer Program Administrators
- Government Agency Leaders
- Pharmacy Students
ISOPP members from developing countries or with financial hardship are offered the opportunity through Travel Grants to attend the ISOPP Symposium so that they may expand their knowledge and share it with colleagues in their home countries or regions.
Symposia coming up
- The 2019 ISOPP Symposium will take place in London, UK.
Inspiring themes
Each ISOPP Symposium has a theme around which the educational program is built. At ISOPP 2018, the theme was:
East Meets West: Past, Present, and Future
The educational program highlighted cutting edge developments and showcased key patient and colleague perspectives. ISOPP 2018 offered a unique opportunity for oncology pharmacy professionals to heighten their practice and continue to elevate our collaborative role within the cancer care team.
Past ISOPP Symposia
Past ISOPP Symposia brought international experts together to learn, discuss and network around clinical, research and fundamental topics in oncology pharmacy. Regional Symposia have also been held in Europe, Australia, and the USA.